RESEARCH ARTICLE
The COVID 19 Pandemic-the Final Straw for Irish Rheumatology Services?
Patrick Mulkerrin1, *, Laura Durcan1, Shawn Chavrimootoo2, David Kane3, Gary Killeen4
Article Information
Identifiers and Pagination:
Year: 2022Volume: 16
E-location ID: e187431292207130
Publisher ID: e187431292207130
DOI: 10.2174/18743129-v16-e2207130
Article History:
Received Date: 21/1/2022Revision Received Date: 20/4/2022
Acceptance Date: 16/5/2022
Electronic publication date: 30/08/2022
Collection year: 2022
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Introduction:
The COVID-19 pandemic has caused disruption to the worldwide provision of acute and chronic care to patients. The effect has been particularly marked in rheumatology in Ireland, where the ability to provide acute and chronic care has been dramatically curtailed due to the combined effects of social distancing, staff redeployment and the repurposing of rheumatology units. Prior to the pandemic, there were significant challenges from an infrastructural and staffing level in Irish rheumatology.
Methods:
Using a questionnaire, the authors evaluated the effect of the first wave of the COVID 19 pandemic on rheumatology services.
Results:
Responses from 87% of Rheumatology specialist services in Ireland indicate that 83% of review appointments were remote, with 87% of new patient assessments in OPD were “in person”. Only 41% of usual outpatient activity could occur within existing infrastructure given guidelines re social distancing which would result a shortfall of 42000 patient appointments. Significant numbers of staff were reassigned from Rheumatology to services elsewhere.
Conclusion:
The COVID-19 pandemic has had a significant negative impact on access to struggling Irish Rheumatology services. Implementation of agreed recommendations for augmenting services must occur urgently.
